Table 1.

Summary of findings from case reports and series used for this narrative review.

Authors	Age	Sex	Diagnosis	Identified risk factor	Biopsy results	Treatment	Dialysis/Renal transplant	Outcome
1. Yuruktumen et al, 2004[10]	64	M	Acute renal failure	Neurogenic lower urinary tract dysfunction	NA	Urinary catheterization	No	Resolved
2. Tornes et al, 2012[11]	41	F	Glomerulonephritis	IFN β-1a	FSGS	Stopping the offending drug	No	Resolved
3. Ozturk et al, 2016[12]	32	M	Glomerulonephritis	IFN β-1a	FSGS	Stopping the offending drug	No	Resolved
4. Auty and Seleh, 2005[13]	28	M	Glomerulonephritis	IFN β-1a	MG	Stopping the offending drug	No	Resolved
5. Wallbach et al, 2013[14]	40	F	Glomerulonephritis	IFN β-1a	MPGN	Replacing IFN-1b with glatiramer acetate	No	Resolved
6. Mahe et al, 2013[15]	38	F	Renal TMA	IFN β-1a	TMA	Stopping the offending drug	No	Progressed
7. Kumasaka et al, 2006[16]	43	F	Glomerulonephritis	IFN β-1b	MCD	Stopping the offending drug	No	Resolved
8. *Markowitz et al, 2010[17]	27	F	Glomerulonephritis	IFN β-1a	FSGS	Stopping the offending drug	No	Unknown
*Markowitz et al, 2010[17]	33	F	Glomerulonephritis	IFN β-1b	FSGS	Stopping the offending drug	No	Resolved
*Markowitz et al, 2010[17]	37	F	Glomerulonephritis	IFN β- 1a	FSGS	Stopping the offending drug	No	Resolved
9. Omoto et al, 2018[18]	42	F	Renal TMA	IFN β- 1b	TMA	Stopping the offending drug	No	Resolved
10. Broughton et al, 2011[19]	53	F	Renal TMA	IFN β-1b	TMA	Stopping the offending drug	No	Progressed
11. Baghbanian and Moghadasi et al, 2018[20]	38	F	Renal TMA	IFN β-1a	TMA	Stopping the offending drug	No	Resolved

F = female, FSGS = focal segmental glomerulosclerosis, IFN β-1a = interferon β-1a, IFN β-1b = interferon β-1b, M = male, MCD = minimal change disease, MG = membranous glomerulonephritis, MPGN = membranoproliferative glomerulonephritis, NA = not available, TMA = thrombotic microangiopathy.

*indicating case series.